MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-01-0033970
Captalo Pharma Private Limited
Captalo Pharma Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹3.61 Cr
▲ 304% YoY
Net loss · FY 2024
₹35.86 Lakh
Net margin -9.9%
EBITDA · FY 2024
₹86.25 Lakh
EBITDA margin 23.9%
Authorised capital
₹2.25 Cr
Registered with MCA
Paid-up capital
₹2.25 Cr
Issued & subscribed
Open charges
₹5.4 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
4
As per MCA filings
About Captalo Pharma Private Limited
Data last updated:
Captalo Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 May 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U33119GJ2020PTC113595. Its GSTIN is 24AAICC7177P1ZZ (Gujarat).
The company has an authorised share capital of ₹2.25 Cr and a paid-up capital of ₹2.25 Cr. It is led by directors including Patel Jignesh Ramanbhai and Pragneshkumar Jayantilal Pathak.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 21 – 2 Avadhpuri Society Nr. Olive Reside Ncy Nr. Shubhvilla Bunglow Bopal, Ahmedabad, Gujarat, India – 380058.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.61 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹35.86 Lakh (net margin -9.9%) and EBITDA of ₹86.25 Lakh (EBITDA margin 23.9%).
As per MCA filings, the company has open charges of ₹5.4 Cr on record.
Captalo Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0033970).
Company details
CIN U33119GJ2020PTC113595
Registration Number 113595
Incorporation Date 20 May 2020
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Small
Udyam Registration UDYAM-GJ-01-0033970
Key People
Patel Jignesh Ramanbhai Director Pragneshkumar Jayantilal Pathak Director Tejendrakumar Laljibhai Patel Director Recognitions & Rankings of Captalo Pharma
Contact details
Captalo Pharma Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address is in the company report.
- Email
- Registered Address21 – 2 Avadhpuri Society Nr. Olive Reside Ncy Nr. Shubhvilla Bunglow Bopal, Ahmedabad, Gujarat, India – 380058
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Captalo Pharma Private Limited, buy the company report.
Comprehensive company report
Captalo Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Captalo Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Captalo Pharma Private Limited, buy the company report.
Financials of Captalo Pharma Private Limited
FY 2025 filings availableCaptalo Pharma Private Limited reported revenue of ₹3.61 Cr (up 304% YoY) for FY 2024.
Revenue · FY 2024
₹3.61 Cr ▲ 304%
Net loss · FY 2024
₹35.86 Lakh margin -9.9%
EBITDA · FY 2024
₹86.25 Lakh margin 23.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 304%
EBITDA CAGR growth
1 year
▲ 878%
Revenue rose 304% in the latest year. EBITDA rose 878% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹86.25 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹35.86 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 23.9% | |||
| Net Profit Margin | -9.9% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Captalo Pharma Private Limited, buy the company report.
Board of directors of Captalo Pharma Private Limited
Captalo Pharma has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Patel Jignesh Ramanbhai | Director | 22 Jul 2020 | 6 Years 3 Months | Current |
| Pragneshkumar Jayantilal Pathak | Director | 20 May 2020 | 6 Years 5 Months | Current |
| Tejendrakumar Laljibhai Patel | Director | 20 May 2020 | 6 Years 5 Months | Current |
| Laljibhai Gandabhai Patel | Director | 20 May 2020 | 6 Years 5 Months | Current |
Peer comparison
Captalo Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Parthvimeda Gau Pharma Private Limited | ₹3.63 Cr (FY 2025) | 42698.0% | Ahmedabad, Gujarat, India | |||
| Baxil Pharma Private Limited | ₹3.62 Cr (FY 2025) | -47.0% | Delhi, India | |||
| Captalo Pharma Private Limitedthis company | ₹3.61 Cr (FY 2024) | -₹35.86 Lakh | -9.9% | 304.0% | Ahmedabad, Gujarat, India | |
| Ceza Formulations Private Limited | ₹3.6 Cr (FY 2024) | 50.0% | Indore, Madhya Pradesh, India |
To see the full peer comparison of Captalo Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5.4 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Feb 2023 | 100676049 | Others | ₹1.25 Cr | Open | |
| 23 Mar 2021 | 100427354 | Sidbi | ₹4.15 Cr | Open |
To see the full charge records of Captalo Pharma Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Captalo Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Captalo Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Captalo Pharma Private Limited has 1 active EPFO establishment as of Mar 31, 2024.
Active EPFO establishments
1
GST
Captalo Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAICC7177P1ZZ | Gujarat | Active | 19 Aug 2020 |
To see the full GST registrations and return filing status of Captalo Pharma Private Limited, buy the company report.
Recent activity
Captalo Pharma Private Limited has 4 board changes on record since 2020: 4 appointments. The latest: Patel Jignesh Ramanbhai was appointed as Director on 22 Jul 2020.
AGM
Captalo Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Captalo Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Others of Rs. 1.25 Cr registered on 10 Feb 2023 with Charge ID 100676049 was modified on 15 Jul 2024.
Charges
A charge with Others amounted to Rs. 1.25 Cr with Charge ID 100676049 was registered on 10 Feb 2023.
Charges
A charge with Sidbi amounted to Rs. 4.15 Cr with Charge ID 100427354 was registered on 23 Mar 2021.
Appointed
Patel Jignesh Ramanbhai was appointed as Director.
Appointed
Laljibhai Gandabhai Patel was appointed as Director.
Appointed
Pragneshkumar Jayantilal Pathak was appointed as Director.
Appointed
Tejendrakumar Laljibhai Patel was appointed as Director.
Incorporation
20 May 2020
Captalo Pharma Private Limited was registered on 20 May 2020 with Roc Ahmedabad & aged 6 years 5 months as per MCA records.
Frequently asked questions
Captalo Pharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 May 2020 (6+ years old) and is registered under CIN U33119GJ2020PTC113595.
Captalo Pharma has 4 current directors:
- Patel Jignesh Ramanbhai - Director
- Pragneshkumar Jayantilal Pathak - Director
- Tejendrakumar Laljibhai Patel - Director
- Laljibhai Gandabhai Patel - Director
The latest financial statements of Captalo Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Captalo Pharma is 24AAICC7177P1ZZ, registered in Gujarat.
The CIN (Corporate Identification Number) of Captalo Pharma is U33119GJ2020PTC113595. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Captalo Pharma was incorporated on 20 May 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Captalo Pharma by revenue are Parthvimeda Gau Pharma Private Limited, Baxil Pharma Private Limited, Ceza Formulations Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Patel Jignesh Ramanbhai was appointed as Director on 22 Jul 2020. Laljibhai Gandabhai Patel was appointed as Director on 20 May 2020. Pragneshkumar Jayantilal Pathak was appointed as Director on 20 May 2020. Captalo Pharma has 4 board changes on record in total.
Yes, Captalo Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-01-0033970).
The registered office of Captalo Pharma is at 21 – 2 Avadhpuri Society Nr. Olive Reside Ncy Nr. Shubhvilla Bunglow Bopal, Ahmedabad, Gujarat, India – 380058.
Captalo Pharma operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages